These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29923504)

  • 1. Comparison of microdosimetry-based absorbed doses to control tumours and clinically obtained tumour absorbed doses in treatments with
    Mínguez P; Roeske JC; Mínguez R; de Iturriaga AG; Rodeño E
    Phys Med Biol; 2018 Jul; 63(14):145005. PubMed ID: 29923504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microdosimetry-based determination of tumour control probability curves for treatments with
    Mínguez Gabiña P; Roeske JC; Mínguez R; Rodeño E; Gómez de Iturriaga A
    Phys Med Biol; 2020 Nov; 65(23):235012. PubMed ID: 33245058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of
    Murray I; Chittenden SJ; Denis-Bacelar AM; Hindorf C; Parker CC; Chua S; Flux GD
    Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1832-1844. PubMed ID: 28612079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetry of bone metastases in targeted radionuclide therapy with alpha-emitting (223)Ra-dichloride.
    Pacilio M; Ventroni G; De Vincentis G; Cassano B; Pellegrini R; Di Castro E; Frantellizzi V; Follacchio GA; Garkavaya T; Lorenzon L; Ialongo P; Pani R; Mango L
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):21-33. PubMed ID: 26266887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Normal Organ Absorbed Doses for [177Lu]Lu-PSMA-617 Using [44Sc]Sc-PSMA-617 Pharmacokinetics in Patients With Metastatic Castration Resistant Prostate Carcinoma.
    Khawar A; Eppard E; Sinnes JP; Roesch F; Ahmadzadehfar H; Kürpig S; Meisenheimer M; Gaertner FC; Essler M; Bundschuh RA
    Clin Nucl Med; 2018 Jul; 43(7):486-491. PubMed ID: 29688951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calculation of radium-223 and actinium-225 α-emitter radiopharmaceuticals dose rates in treatment of metastatic castration-resistant prostate cancer.
    Abbasi A; Dadashpour M; Alipourfard I
    J Cancer Res Ther; 2021; 17(2):348-352. PubMed ID: 34121676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic investigation on the validity of partition model dosimetry for
    Hashikin NAA; Yeong CH; Guatelli S; Abdullah BJJ; Ng KH; Malaroda A; Rosenfeld A; Perkins AC
    Phys Med Biol; 2017 Aug; 62(18):7342-7356. PubMed ID: 28686171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Monte Carlo study of macroscopic and microscopic dose descriptors for kilovoltage cellular dosimetry.
    Oliver PA; Thomson RM
    Phys Med Biol; 2017 Feb; 62(4):1417-1436. PubMed ID: 28114113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and quantification of
    Mínguez P; Gómez de Iturriaga A; Fernández IL; Rodeño E
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(1):20-27. PubMed ID: 28645684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation Dosimetry for
    Okamoto S; Thieme A; Allmann J; D'Alessandria C; Maurer T; Retz M; Tauber R; Heck MM; Wester HJ; Tamaki N; Fendler WP; Herrmann K; Pfob CH; Scheidhauer K; Schwaiger M; Ziegler S; Eiber M
    J Nucl Med; 2017 Mar; 58(3):445-450. PubMed ID: 27660138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetry for (177)Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer.
    Delker A; Fendler WP; Kratochwil C; Brunegraf A; Gosewisch A; Gildehaus FJ; Tritschler S; Stief CG; Kopka K; Haberkorn U; Bartenstein P; Böning G
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):42-51. PubMed ID: 26318602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction factors for source strength determination in HDR brachytherapy using the in-phantom method.
    Ubrich F; Wulff J; Engenhart-Cabillic R; Zink K
    Z Med Phys; 2014 May; 24(2):138-52. PubMed ID: 24021956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case report of image-based dosimetry of bone metastases with Alpharadin ((223)Ra-dichloride) therapy: inter-fraction variability of absorbed dose and follow-up.
    Pacilio M; Ventroni G; Cassano B; Ialongo P; Lorenzon L; Di Castro E; Recine F; Sternberg CN; Mango L
    Ann Nucl Med; 2016 Feb; 30(2):163-8. PubMed ID: 26613714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cell-based dosimetry model for radium-223 dichloride therapy using bone micro-CT images and GATE simulations.
    Pinto GM; Bonifacio DAB; de Sá LV; Lima LFC; Vieira IF; Lopes RT
    Phys Med Biol; 2020 Feb; 65(4):045010. PubMed ID: 31935695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D calculation of absorbed dose for 131I-targeted radiotherapy: a Monte Carlo study.
    Saeedzadeh E; Sarkar S; Abbaspour Tehrani-Fard A; Ay MR; Khosravi HR; Loudos G
    Radiat Prot Dosimetry; 2012 Jul; 150(3):298-305. PubMed ID: 22069233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of 223Ra-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases.
    Chittenden SJ; Hindorf C; Parker CC; Lewington VJ; Pratt BE; Johnson B; Flux GD
    J Nucl Med; 2015 Sep; 56(9):1304-9. PubMed ID: 26182965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of single dose radium-223 dichloride (BAY 88-8223) in Japanese patients with castration-resistant prostate cancer and bone metastases.
    Yoshida K; Kaneta T; Takano S; Sugiura M; Kawano T; Hino A; Yamamoto T; Shizukuishi K; Kaneko M; Zurth C; Inoue T
    Ann Nucl Med; 2016 Aug; 30(7):453-60. PubMed ID: 27272279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extraction of
    Großer OS; Wissel H; Wallbaum T; Genseke P; Kupitz D; Ricke J; Ruf J; Amthauer H
    Nuklearmedizin; 2017 Jun; 56(3):69-72. PubMed ID: 28383088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric characterization of two radium sources for retrospective dosimetry studies.
    Candela-Juan C; Karlsson M; Lundell M; Ballester F; Tedgren ÅC
    Med Phys; 2015 May; 42(5):2132-42. PubMed ID: 25979008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New dosimetry for childhood skin hemangioma treatments with (226)Ra needles or tubes.
    Lundell M; Karlsson M; Carlsson Tedgren Å
    Radiother Oncol; 2015 Jul; 116(1):139-42. PubMed ID: 26104976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.